| 缩写名/全名 |
CRIT REV ONCOL HEMAT
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
||||||||||||||||||||||||
| ISSN号 | 1040-8428 | ||||||||||||||||||||||||
| 研究方向 | 医学-血液学 | ||||||||||||||||||||||||
| 影响因子 | 2015:5.039, 2016:4.971, 2017:4.495, 2018:5.012, 2019:5.833, | ||||||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||||||
| 年文章数 | 188 | ||||||||||||||||||||||||
| 出版年份 | 1983 | ||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||
| 审稿周期(仅供参考) | 偏慢,4-8周 来源Elsevier官网：平均27.3周 |
||||||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||||||
| 投稿链接 | http://ees.elsevier.com/croh | ||||||||||||||||||||||||
| 投稿官网 | http://www.croh-online.com/ | ||||||||||||||||||||||||
| h-index | 111 | ||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D | ||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Impact of age on the overall survival benefits of anti-EGFR-containing regimens in head and neck squamous cell carcinoma: A meta-analysis of randomized controlled trials Author: Yuguang Zhao, Wenhui Liu, Meiting Sun, Qiuli Miao, Yingmin Liu, Huimin Tian, Yapin Su, Fujun Han Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 39-46, DOI:10.1016/j.critrevonc.2019.01.017 DOI |
| 2. | The roles of EBV-encoded microRNAs in EBV-associated tumors Author: Min Dong, Jian-ning Chen, Jun-ting Huang, Li-ping Gong, Chun-kui Shao Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 30-38, DOI:10.1016/j.critrevonc.2019.01.014 DOI |
| 3. | Corrigendum to “Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy” [Crit. Rev. Oncol./Hematol. 128 (August) (2018) 110–117] Author: Bin Zhao, Hong Zhao, Jiaxin Zhao Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol.135, 20, DOI:10.1016/j.critrevonc.2019.01.007 DOI |
| 4. | Combination versus mono-therapy as second-line treatment for advanced biliary tract cancer: a systematic review and meta-analysis of published data Author: Jie Ying, Jinfei Chen Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, Vol., , DOI:10.1016/j.critrevonc.2019.01.001 DOI |
| 5. | Diarrhea with epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients: A meta-analysis of randomized controlled trials Author: Jing Li, Jian Gu Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, Vol.134, 31-38, DOI:10.1016/j.critrevonc.2018.12.001 DOI |
| 6. | Impact of PET/CT on radiation treatment in patients with esophageal cancer: A systematic review Author: Jing Lu, Xiang-dong Sun, Xi Yang, Xin-yu Tang, Qin Qin, Hong-cheng Zhu, Hong-yan Cheng, Xin-chen Sun Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, Vol.107, 128-137, DOI:10.1016/j.critrevonc.2016.08.015 DOI |
| 7. | Aptamers in hematological malignancies and their potential therapeutic implications Author: Wanyan Ouyang, Ziqiang Yu, Xiaohong Zhao, Shiyun Lu, Zhi Wang Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, Vol.106, 108-117, DOI:10.1016/j.critrevonc.2016.08.003 DOI |
| 8. | TP53 dysfunction in diffuse large B-cell lymphoma. Author: Lu TX, Young KH, Xu W, Li JY. Journal: Crit Rev Oncol Hematol. 2016 Jan;97:47-55. doi: 10.1016/j.critrevonc.2015.08.006. Epub 2015 Aug 10. Review. PubMed |
| 9. | Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy. Author: Shan NN, Dong LL, Zhang XM, Liu X, Li Y. Journal: Crit Rev Oncol Hematol. 2016 Apr;100:11-5. doi: 10.1016/j.critrevonc.2016.01.011. Epub 2016 Jan 19. Review. PubMed |
| 10. | Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis. Author: Flamini V, Jiang WG, Lane J, Cui YX. Journal: Crit Rev Oncol Hematol. 2016 Apr;100:177-89. doi: 10.1016/j.critrevonc.2016.02.010. Epub 2016 Feb 18. Review. PubMed |
|
|
